Analystreport

PTC Therapeutics (NASDAQ:PTCT) had its price target raised by analysts at TD Cowen from $50.00 to $63.00. They now have a "hold" rating on the stock.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com